The Myeloma Institute for Research and Therapy is the number one choice for myeloma treatment throughout the world. Our physicians and scientists have one overriding goal: to achieve cure in patients with multiple myeloma.
Our history of conducting research and delivering therapy has brought about fundamental changes in the approach to treating myeloma. As a result, we have seen substantial improvements in patient outcomes, including response to treatments, remission, and long-term survival.
At the Myeloma Institute,
- patients diagnosed with low-risk multiple myeloma can experience more than a decade of survival.
- patients with high-risk multiple myeloma can benefit from new therapies discovered with our translational research.
- patients receive therapies targeted to specific molecular subtypes of myeloma, allowing them to receive the most effective treatment with the minimum amount of side effects.
- most patients are treated on an outpatient basis, even when stem-cell transplant is part of the treatment regimen.
Explore our website to learn more about treatment at the Myeloma Institute.
Total Therapy Approach